PERP_B: Q4 revenue jumped 62% on ES-Medical, with improved losses and strong cash flow

About this update from Perpetua Medical Ab Class B

Revenue surged in Q4 due to the ES-Medical acquisition, but full-year sales declined after divestments. Operating losses narrowed sharply, cash position improved, and the company remains focused on acquisitions and cost discipline. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Perpetua Medical Ab Class B